Clinical and molecular spectrum of patients with 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency;Espectro clínico e molecular de pacientes com deficiência de 17β-hidroxiesteroide desidrogenase tipo 2 (17-β-HSD3)

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 56, Issue 8, 2012, Pages 533-539

  Castro, Carla Cristina Telles de Sousa ^a   Guaragna Filho, Guilherme ^a   Calais, Flavia Leme ^a   Coeli, Fernanda Borchers ^a   Leal, Ianik Rafaela Lima ^b   Cavalcante Junior, Erisvaldo Ferreira ^c   Monlleó, Isabella Lopes ^c   Pereira, Silma Regina Ferreira ^b   e Silva, Roberto Benedito de Paiva ^a,d   Gabiatti, José Roberto Erbolato ^a   Marques de Faria, Antonia Paula ^a,d   Maciel Guerra, Andrea Trevas ^a,d   de Mello, Maricilda Palandi ^a   Guerra Junior, Gil ^a,d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^c FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^d FCMUnicamp   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 3; 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3; HYDROXYSTEROID DEHYDROGENASE;

ADOLESCENT; ARTICLE; CASE REPORT; DISORDER OF SEX DEVELOPMENT; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MUTATION; PRESCHOOL CHILD; XY GONADAL DYSGENESIS;

17-HYDROXYSTEROID DEHYDROGENASES; ADOLESCENT; CHILD, PRESCHOOL; DISORDERS OF SEX DEVELOPMENT; FEMALE; GONADAL DYSGENESIS, 46,XY; HUMANS; MUTATION;

EID: 84872316581     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302012000800012     Document Type: Article

References (32)

1. Andersson S, Moghrabi N. Physiology and molecular genetics of 17beta-hydroxysteroid dehydrogenases. Steroids. 1997;62:143-47.
2. Lukacik P, Kavanagh KL, Oppermann U. Structure and function of human 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol. 2006;248:61-71.
3. Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148-58.
4. George MM, New M I, Tem S, Sultan C, Bhangoo A. The clinical and molecular heterogeneity of 17aHSD3 enzyme deficiency. Horm Res Paediatr. 2010;74:229-40.
5. Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, Andersson S, et al. 17beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab. 1999;84:4713-21.
6. Mendonça BB, Inacio M, Arnhold IJ, Costa EM, Bloise W, Martin RM, et al. Male pseudohermaphroditism due to 17beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore). 2000;79:299-309.
7. Lee YS, Kirk JM, Stanhope RG, Johnston DI, Harland S, Auchus RJ, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf). 2007;67:20-8.
8. Faienza MF, Giordani L, Delvecchio M, Cavallo L. Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency. J Endocrinol Invest. 2008;31:85-91.
9. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, et al. Molecular genetics and pathophysiology of 17 betahydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab. 1996;81:130-6.
10. Mendonca BB, Arnhold IJ, Bloise W, Andersson S, Russell DW, Wilson JD. 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab. 1999;84:802-4.
11. Prehn C, Möller G, Adamski J. Recent advances in 17betahydroxysteroid dehydrogenases. J Steroid Biochem Mol Biol. 2009;114:72-7.
12. Hiort O, Reinecke S, Thyen U, Jurgensen M, Holterhus PM, Schon D, et al. Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab. 2003;16(suppl 2):297-306.
13. Cohen-Kettenis PT. Gender change in 46, XY persons with 5alphareductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav. 2005;34:399-410.
14. Faisal Ahmed S, Iqbal A, Hughes IA. The testosterone: androstenedione ratio in male undermasculinization. Clin Endocrinol (Oxf). 2000;53:697-702.
15. Ben Rhouma B, Belguith N, Mnif MF, Kamoun T, Charfi N, Kamoun M, et al. A novel nonsense mutation in HSD17B3 gene in a Tunisian patient with sexual ambiguity. J Sex Med. 2012 [Epub ahead of print].
16. Neocleous V, Sismani C, Shammas C, Efstathiou E, Alexandrou A, Ioannides M, et al. Duplication of exons 3-10 of the HSD17B3 gene: a novel type of genetic defect underlying 17g-HSD-3 deficiency. Gene. 2012;499:250-5.
17. Sambrook J, Fritsch EF, Maniatis TE. Molecular cloning, a laboratory manual New York: Cold Spring Harbor; 1989.
18. Saez JM, De Peretti E, Morera AM, David M, Bertrand J. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab. 1971;32:604-10.
19. Saez JM, Morera AM, De Peretti E, Bertrand J. Further in vivo studies in male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect (compared to a case of testicular feminization). J Clin Endocrinol Metab. 1972;34:598-600.
20. Rösler A, Silverstein S, Abeliovich D. A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab. 1996;81:1827-31.
21. Rösler A. 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population. Pediatr Endocrinol Rev. 2006;3(suppl 3):455-61.
22. Mckeever BM, Hawkins BK, Geissler WM, Wu L, Sheridan RP, Mosley RT, et al. Amino acid substitution of arginine 80 in 171-hidroxysteroide dehydrogenase 3 and its effect on NADPH cofator binding and oxidation/reduction kinetics. Biochim Biophys Acta. 2002;1601:29-37.
23. Rosler A, Belanger A, Labrie F. Mechanisms of androgen production in male pseudohermaphroditism due to 17b-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1992;75:773-8.
24. Culigan W. Phoenicia and Phoenician colonization. In: Boardman J, Edwards IE, Hammond NG, Sollberger E, Walker CB, eds. The Cambridge ancienty history, 2nd Ed. Cambridge University Press; 1991. p. 461-546.
25. Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton: Princeton University Press; 1994. p. 217, 242-245, 260.
26. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonça BB, et al. Male pseudohermaphroditism caused by mutations of testicular 17o-hidroxysteroide dehydrogenase 3. Nat Genet. 1994;7:34-9.
27. Moghrabi N, Hughes IA, Dunaif A, Andersson S. Deleterious missense mutations and silent polymorphism in the human 17b-hydroxysteroid dehydrogenase 3 gene (hsd17b3). J Clin Endocrinol Metabol. 1998;83(8):2855-60.
28. http://www.ensembl.org/Homo_sapiens/Variation/Population?db=cor e;g=ENSG00000130948;r=9:98997588-99064434;t=ENST00000375263;v=rs2066479;vdb=variation;vf=16374979. Accessed on: Sept 30, 2012.
29. Margiotti K, Kim E, Pearce CL, Spera E, Novelli G, Reichardt JK. Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men. Prostate. 2002;53:65-8.
30. Sata F, Kurahashi N, Ban S, Moriya K, Tanaka KD, Ishizuka M, et al. Genetic polymorphisms of 17 G-hydroxysteroid dehydrogenase 3 and the risk of hypospadias. J Sex Med. 2010;7(8):2729-38.
31. Mains LM, Vakili MB, Lacassie Y, Andersson S, Lindqvistc A, Rock JA. 17beta hydroxysteroid dehydrogenase 3 deficiency in a male Pseudohermaphrodite. Fertil Steril. 2008;89(1):228. e13-228. e17.
32. Lee PA, Houk CP, Faisal A, Hughes IA, International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Pediatrics. 2006;118:488-500.